HIV/HCV co-infection: natural history

被引:0
|
作者
Puoti, M
Prestini, K
Putzolu, V
Zanini, B
Baiguera, C
Antonini, MG
Pagani, R
Airoldi, M
Carosi, G
机构
[1] Univ Brescia, Dipartimento Malattie Infett & Trop, AO Spedali Civili, I-25123 Brescia, Italy
[2] Univ Brescia, Dept Infect & Trop Dis, Brescia, Italy
关键词
HIV; HCV; hepatitis; cirrhosis; hepatocellular carcinoma;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
HIV and HCV share common transmission pathways, but HCV is more efficiently transmitted through blood than with sexual exposure. Thus HCV coinfection is frequent in HIV seropositives, mainly in those with history of injection drug use and/or transfusion. HIV coinfection increases HCV replication rate, the rate of HCV vertical transmission and accelerates the course of hepatitis C towards cirrhosis and hepatocellular carcinoma. The evidence of an effect of HCV on HIV disease progression is less convincing. The results of several studies suggest that HCV coinfection does not hasten the progression of HIV infection towards AIDS. However two recent studies showed that HCV coinfection is independently associated with a lower restoration of CD4 counts during combination antiretroviral treatment. However this finding should be confirmed by additional studies.
引用
收藏
页码:144 / 146
页数:3
相关论文
共 50 条
  • [21] A Study on the HBV and the HCV Infections in Female Sex Workers and their Co-Infection with HIV
    Praseeda, Desai S.
    Anuradha, Dutta
    Jayanthi, Shastri S.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2013, 7 (02) : 234 - 237
  • [23] HIV-HCV co-infection: where are we now?
    Piroth, L.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2009, 33 : S94 - S96
  • [24] Antiviral therapy for HCV in hemophilia A patients with HIV-1 co-infection
    Xiao, Hong
    Chen, Jun
    Wang, Jiangrong
    Li, Juhua
    Yang, Feia
    Lu, Hongzhou
    MEDICINE, 2019, 98 (30)
  • [25] HIV and hepatitis C co-infection: acute HCV therapy
    Boesecke, Christoph
    Vogel, Martin
    CURRENT OPINION IN HIV AND AIDS, 2011, 6 (06) : 459 - 464
  • [26] The assessment of selected MiRNAs profile in HIV, HBV, HCV, HIV/HCV, HIV/HBV Co-infection and elite controllers for determination of biomarker
    Yousefpouran, Sepehr
    Mostafaei, Shayan
    Manesh, Pegah Vahidi
    Iranifar, Elmira
    Bokharaei-Salim, Farah
    Nahand, Javid Sadri
    Mirzaei, Hamed
    Taran, Mojtaba
    Babaei, Farhad
    Sayad, Babak
    Moghoofei, Mohsen
    MICROBIAL PATHOGENESIS, 2020, 147
  • [27] Public Health Considerations among People who Inject Drugs with HIV/HCV Co-Infection: A Review
    Murdock, Rachel M.
    Brizzi, Marisa B.
    Perez, Omar
    Badowski, Melissa E.
    INFECTIOUS DISEASES AND THERAPY, 2019, 8 (01) : 23 - 32
  • [28] A descriptive analysis of concurrent alcohol and substance use among patients living with HIV/HCV co-infection
    Sims, Omar T.
    Wang, Kaiying
    Chandler, Rasheeta
    Melton, Pamela A.
    Truong, Duong N.
    SOCIAL WORK IN HEALTH CARE, 2020, 59 (07) : 525 - 541
  • [29] Assessment of factors associated with the quality of life of patients living with HIV/HCV co-infection
    Pereira, Marco
    Fialho, Renata
    JOURNAL OF BEHAVIORAL MEDICINE, 2016, 39 (05) : 767 - 781
  • [30] HCV treatment with pegylated interferon and ribavirin in patients with haemophilia and HIV/HCV co-infection
    Denholm, J. T.
    Wright, E. J.
    Street, A.
    Sasadeusz, J. J.
    HAEMOPHILIA, 2009, 15 (02) : 538 - 543